First things first, why does Capire360 exist?
Capire360 was created to complement the knowledge and expertise of oncologists by providing evidence-based insight on treatment options based on real-word data.
This was needed because clinical trial data is based on the results of patients who are on average, healthier, younger, and less diverse, Capire360’s real-world data approach augments clinical trial data with data that is representative of the population at large, not just the small number selected to participate in trials.
Our parent company, PotentiaMetrics, maintains one of the largest databases of real-world outcomes, which powers Capire360. Our data is clinical registry data derived from over 500 medical centers, encompassing over 2-million cancer patients – offering more accurate and relevant outcomes information.
This information coupled with discussions with a MyCancerJourney advocate enables true shared decision-making.
Will my advocate use Capire360?
Capire360 is specifically relevant to patients with a new cancer diagnosis. It provides insight into the treatment outcomes of “people like you” for the guideline choices established by the NCCN (National Comprehensive Cancer Network) for your type and stage of cancer.
If you have a new cancer diagnosis, you can provide your MyCancerJourney advocate the relevant information about you: your age, sex, race/ethnicity, any pre-existing health conditions, and about your cancer diagnosis. Then, they can share with you detailed information that can help answer questions based on the experiences of other people like you. For example, what are all the treatment options for my type of cancer? Have certain treatments proven to be more effective than others? Is chemotherapy worth the associated side effects?
With this information, you can make decisions that best align with what matters most to you, based on insights meaningful to you. After all, every patient’s journey is unique, and there is no one-size-fits-all solution.
Data You Can Trust
PotentiaMetrics spent a decade developing and testing Capire360 within top medical schools. The statistical models that power Capire360 are tested internally and externally, ensuring they accurately reflect survival outcomes.
Experts in healthcare analytics from the Erasmus University Medical Center, including Professor Ewout Steyerberg, one of the world’s top specialists in medical decision-making and prognostic modeling, have validated the models and their methodology.
Capire360 is updated annually, continuously reviewed by oncologists, and compared to data from the National Cancer Institute’s SEER database to ensure accuracy and confirm clinical value.
Still Have Questions?
Check out our full list of frequently asked questions or submit a question here.
Office
901 S. Mopac Expy.
Bldg. 1, Ste. 300
Austin, TX 78746
Bldg. 1, Ste. 300
Austin, TX 78746
Email us
info@mycancerjourney.com
Call us
737 307 0001